Cargando…

Flash glucose monitoring improves glycemia in higher risk patients: a longitudinal, observational study under real-life settings

OBJECTIVE: To assess the role of flash glucose monitoring in early and late changes in glycemic markers under real-life conditions. RESEARCH DESIGN AND METHODS: Deidentified glucose results from 6802 flash glucose monitors were analyzed after dividing into high, medium and low-risk groups based on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jangam, Sujit, Dunn, Timothy, Xu, Yongjin, Hayter, Gary, Ajjan, Ramzi A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501858/ https://www.ncbi.nlm.nih.gov/pubmed/31114698 http://dx.doi.org/10.1136/bmjdrc-2018-000611

Ejemplares similares

Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain
por: Gomez-Peralta, Fernando, et al.
Publicado: (2020)

Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)
por: Fokkert, Marion, et al.
Publicado: (2019)

Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
por: Castellana, Marco, et al.
Publicado: (2020)

Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6)
por: Lameijer, Annel, et al.
Publicado: (2021)

FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis
por: Blissett, Robert, et al.
Publicado: (2022)

Commencement of flash glucose monitoring is associated with a decreased rate of depressive disorders among persons with diabetes (FLARE-NL7)
por: Bakker, Julia J, et al.
Publicado: (2022)

Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus
por: Fokkert, M J, et al.
Publicado: (2017)

Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial
por: Wada, Eri, et al.
Publicado: (2020)

Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept
por: Bent, Brinnae, et al.
Publicado: (2021)

Time in range–A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study
por: Valenzano, Marina, et al.
Publicado: (2021)

Impact of Ramadan fasting on glucose levels in women with gestational diabetes mellitus treated with diet alone or diet plus metformin: a continuous glucose monitoring study
por: Afandi, Bachar O, et al.
Publicado: (2017)

Strains of Faecalibacterium prausnitzii and its extracts reduce blood glucose levels, percent HbA1c, and improve glucose tolerance without causing hypoglycemic side effects in diabetic and prediabetic mice
por: Kallassy, John, et al.
Publicado: (2023)

Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
por: Ferrannini, Giulia, et al.
Publicado: (2015)

Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
por: Tao, Rui, et al.
Publicado: (2021)

Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
por: Riddy, Darren M, et al.
Publicado: (2021)

Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
por: Smith, Ian P, et al.
Publicado: (2023)

Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review
por: Raj, Rishi, et al.
Publicado: (2022)

Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study
por: Di Dalmazi, Guido, et al.
Publicado: (2020)

Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit
por: Kosiborod, Mikhail, et al.
Publicado: (2014)

Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation
por: Perraudeau, Fanny, et al.
Publicado: (2020)

Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE
por: Klein, Klara R, et al.
Publicado: (2021)

Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp
por: Ly, Trang T., et al.
Publicado: (2014)

Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study
por: Horii, Takeshi, et al.
Publicado: (2020)

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
por: Weiss, Tracey, et al.
Publicado: (2022)

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
por: Ghazi, Tara, et al.
Publicado: (2014)

Comparison of weight-based insulin titration (WIT) and glucose-based insulin titration using basal-bolus algorithm in hospitalized patients with type 2 diabetes: a multicenter, randomized, clinical study
por: Zhang, Xiaodan, et al.
Publicado: (2020)

Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose
por: Sherr, Jennifer L., et al.
Publicado: (2014)

Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)
por: Desouza, Cyrus, et al.
Publicado: (2020)

Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study
por: Inagaki, Nobuya, et al.
Publicado: (2017)

Unilateral remote temperature monitoring to predict future ulceration for the diabetic foot in remission
por: Lavery, Lawrence A, et al.
Publicado: (2019)

Comparative Effects of Prolonged and Intermittent Stimulation of the Glucagon-Like Peptide 1 Receptor on Gastric Emptying and Glycemia
por: Umapathysivam, Mahesh M., et al.
Publicado: (2014)

Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice
por: Gómez-Valadés, Alicia G., et al.
Publicado: (2008)

Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial
por: Hásková, Aneta, et al.
Publicado: (2020)

Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study
por: Shima, Kosuke Robert, et al.
Publicado: (2018)

Validity and reliability of anti-diabetic medication adherence scale among patients with diabetes in Baghdad, Iraq: a pilot study
por: Mikhael, Ehab Mudher, et al.
Publicado: (2019)

HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs
por: Fritsche, Andreas, et al.
Publicado: (2019)

Testing the sympathetic nervous system of the foot has a high predictive value for early amputation in patients with diabetes with a neuroischemic ulcer
por: Schreuder, Sanne M, et al.
Publicado: (2018)

Engagement and outcomes in a digital Diabetes Prevention Program: 3-year update
por: Sepah, S Cameron, et al.
Publicado: (2017)

Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world
por: Dailey, George, et al.
Publicado: (2019)

Metabolic and energetic benefits of microRNA-22 inhibition
por: Thibonnier, Marc, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_thr723l0t3i3e1jv0gambg59f1